Hemoglobin-glutamer 250 (Bovine) [HBOC-201, Hemopure®] Clinical Use in South Africa and Comprehensive Review of Cardiac Outcomes and Risk/Benefit in Peer-Reviewed, Indexed Studies in Humans and Animal Models

Regenerative Medicine, Artificial Cells and NanomedicineNanobiotherapeutic Based Blood Substitutes, pp. 207-247 (2022) Free AccessChapter 3.2: Hemoglobin-glutamer 250 (Bovine) [HBOC-201, Hemopure®] Clinical Use in South Africa and Comprehensive Review of Cardiac Outcomes and Risk/Benefit in Peer-Reviewed, Indexed Studies in Humans and Animal ModelsJonathan S. Jahr, Kelly Tseng, Adam P Brown and Gregory P DubéJonathan S. JahrDepartment of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine at UCLA, USADepartment of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine at UCLA — Ronald Reagan UCLA Medical Center, 757 Westwood Plaza, Suite 3325, Los Angeles, California 90095, USA, Kelly TsengMassachusetts General Hospital, Harvard University School of Medicine, USA, Adam P BrownUniversity of Kansas School of Medicine, USA and Gregory P DubéHemoglobin Oxygen Therapeutics, Souderton, Pennsylvania, USAhttps://doi.org/10.1142/9789811228698_0008Cited by:0 PreviousNext AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsRecommend to Library ShareShare onFacebookTwitterLinked InRedditEmail Abstract: The following sections are included: Introduction Clinical Use in South Africa Worsened or Improved Cardiac Outcomes: A Comprehensive Review of Risk/Benefit in Peer-Reviewed, Indexed Studies in Humans and Animal Models Discussion Summary Acknowledgments References Keywords: Blood substituteoxygen therapeuticcardiotoxicityhemopure®hemoglobin-glutamer 250 (bovine)HBOC-201Hemopure® FiguresReferencesRelatedDetails Nanobiotherapeutic Based Blood SubstitutesMetrics History KeywordsBlood substituteoxygen therapeuticcardiotoxicityhemopure®hemoglobin-glutamer 250 (bovine)HBOC-201Hemopure®PDF download